260 related articles for article (PubMed ID: 30243414)
1. Peer navigation and take-home naloxone for opioid overdose emergency department patients: Preliminary patient outcomes.
Samuels EA; Bernstein SL; Marshall BDL; Krieger M; Baird J; Mello MJ
J Subst Abuse Treat; 2018 Nov; 94():29-34. PubMed ID: 30243414
[No Abstract] [Full Text] [Related]
2. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.
Katzman JG; Takeda MY; Greenberg N; Moya Balasch M; Alchbli A; Katzman WG; Salvador JG; Bhatt SR
JAMA Netw Open; 2020 Feb; 3(2):e200117. PubMed ID: 32101312
[TBL] [Abstract][Full Text] [Related]
3. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
4. Emergency department naloxone rescue kit dispensing and patient follow-up.
Kaucher KA; Acquisto NM; Broderick KB
Am J Emerg Med; 2018 Aug; 36(8):1503-1504. PubMed ID: 29237542
[No Abstract] [Full Text] [Related]
5. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder.
Herring AA; Schultz CW; Yang E; Greenwald MK
Am J Emerg Med; 2019 Dec; 37(12):2259-2262. PubMed ID: 31239086
[No Abstract] [Full Text] [Related]
6. Relay: A Peer-Delivered Emergency Department-Based Response to Nonfatal Opioid Overdose.
Welch AE; Jeffers A; Allen B; Paone D; Kunins HV
Am J Public Health; 2019 Oct; 109(10):1392-1395. PubMed ID: 31415200
[TBL] [Abstract][Full Text] [Related]
7. An increase in per-patient naloxone requirements in an opioid epidemic.
Birmingham LE; Nielson JA
Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907
[No Abstract] [Full Text] [Related]
8. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
[TBL] [Abstract][Full Text] [Related]
9. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
[TBL] [Abstract][Full Text] [Related]
10. A 20-Year-Old Woman With Severe Opioid Toxicity.
Solomon R
J Emerg Nurs; 2018 Jan; 44(1):77-78. PubMed ID: 28427726
[No Abstract] [Full Text] [Related]
11. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Is nebulised naloxone effective in opioid overdose?
Ishiyama D; Jones J
Emerg Med J; 2013 Oct; 30(10):860. PubMed ID: 24014692
[TBL] [Abstract][Full Text] [Related]
12. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
13. Fentanyl misuse.
Ruzycki S; Yarema M
CMAJ; 2016 Jun; 188(9):673. PubMed ID: 27091798
[No Abstract] [Full Text] [Related]
14. Implementing take-home naloxone in an urban community pharmacy.
Akers JL; Hansen RN; Oftebro RD
J Am Pharm Assoc (2003); 2017; 57(2S):S161-S167. PubMed ID: 28202384
[TBL] [Abstract][Full Text] [Related]
15. Higher naloxone dosing may be required for opioid overdose.
Bardsley R
Am J Health Syst Pharm; 2019 Oct; 76(22):1835-1837. PubMed ID: 31665765
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with naloxone administration in an opioid dependent sample.
Kenney SR; Anderson BJ; Bailey GL; Stein MD
J Subst Abuse Treat; 2018 Jan; 84():17-20. PubMed ID: 29195589
[TBL] [Abstract][Full Text] [Related]
17. Bringing naloxone to ground zero: Huntington, West Virginia.
Babcock C; Rockich-Winston N; Booth C
J Am Pharm Assoc (2003); 2017; 57(2S):S9-S10. PubMed ID: 27838389
[No Abstract] [Full Text] [Related]
18. Pharmacist-led health-system approaches to reduce opioid overdose and death.
Saldaña SN; Weaver N; Stanford B
J Am Pharm Assoc (2003); 2017; 57(2S):S8-S9. PubMed ID: 27865761
[No Abstract] [Full Text] [Related]
19. Implementing an overdose education and naloxone distribution program in a health system.
Devries J; Rafie S; Polston G
J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
[TBL] [Abstract][Full Text] [Related]
20. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
